Rachel J Gorwitz

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004
    Rachel J Gorwitz
    National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 197:1226-34. 2008
  2. ncbi A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections
    Rachel J Gorwitz
    Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pediatr Infect Dis J 27:1-7. 2008
  3. ncbi Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004
    Fernanda C Lessa
    Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 28:577-81. 2009
  4. ncbi Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and update
    Rachel J Gorwitz
    Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 27:925-6. 2008
  5. ncbi Methicillin-resistant Staphylococcus aureus: a primer for dentists
    R Monina Klevens
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Am Dent Assoc 139:1328-37. 2008
  6. ncbi Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections
    Fernanda C Lessa
    Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 55:232-41. 2012
  7. ncbi Mupirocin resistance
    Jean B Patel
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 49:935-41. 2009
  8. ncbi Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the community
    Rachel J Gorwitz
    J Infect Dis 197:179-82. 2008
  9. ncbi The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus
    Rachel J Gorwitz
    Clin Infect Dis 44:785-7. 2007
  10. ncbi High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center
    Linda L Han
    State Laboratory Institute, 305 South St, Jamaica Plain, MA 02130, USA
    J Clin Microbiol 45:1350-2. 2007

Detail Information

Publications11

  1. ncbi Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004
    Rachel J Gorwitz
    National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 197:1226-34. 2008
    ..Staphylococcus aureus is a common cause of infection, particularly in persons colonized by this organism. Virulent strains of methicillin-resistant S. aureus (MRSA) have emerged in the general community...
  2. ncbi A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections
    Rachel J Gorwitz
    Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pediatr Infect Dis J 27:1-7. 2008
    ..Educating patients on strategies to prevent further transmission is a critical component of case management. More data are needed to determine optimal strategies for management and prevention of MRSA skin infections in the community...
  3. ncbi Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004
    Fernanda C Lessa
    Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 28:577-81. 2009
    ..We assessed the scope and magnitude of MRSA infections with disease onset after 3 days of age (late-onset MRSA infections) in NICUs...
  4. ncbi Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and update
    Rachel J Gorwitz
    Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 27:925-6. 2008
  5. ncbi Methicillin-resistant Staphylococcus aureus: a primer for dentists
    R Monina Klevens
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Am Dent Assoc 139:1328-37. 2008
    ....
  6. ncbi Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections
    Fernanda C Lessa
    Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 55:232-41. 2012
    ..However, its impact on patient outcomes has not been well studied. We evaluated patients with invasive MRSA infections to assess differences in outcomes between infections caused by USA100 and those caused by USA300...
  7. ncbi Mupirocin resistance
    Jean B Patel
    Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 49:935-41. 2009
    ..Institutions that are considering the implementation of widespread mupirocin use should consider these resistance issues and develop strategies to monitor the impact of mupirocin use...
  8. ncbi Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the community
    Rachel J Gorwitz
    J Infect Dis 197:179-82. 2008
  9. ncbi The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus
    Rachel J Gorwitz
    Clin Infect Dis 44:785-7. 2007
  10. ncbi High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center
    Linda L Han
    State Laboratory Institute, 305 South St, Jamaica Plain, MA 02130, USA
    J Clin Microbiol 45:1350-2. 2007
    ..The clindamycin, tetracycline, and mupirocin resistance genes identified in these isolates are commonly associated with plasmids...
  11. ncbi Methicillin-resistant S. aureus infections among patients in the emergency department
    Gregory J Moran
    Department of Emergency Medicine, Olive View UCLA Medical Center, Sylmar, Calif 91342, USA
    N Engl J Med 355:666-74. 2006
    ..Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly recognized in infections among persons in the community without established risk factors for MRSA...